Publication Name	World Journal of Gastroenterology
Manuscript ID	72579
Country	China

Received	2021-10-21 11:53
Peer-Review Started	2021-10-21 11:55
To Make the First Decision
Return for Revision	2021-12-27 02:38
Revised	2022-01-06 15:17
Second Decision	2022-03-14 05:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-03-16 09:27
Articles in Press	2022-03-16 09:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-04-01 11:05
Publish the Manuscript Online	2022-04-15 08:25

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Letter to the Editor
Article Title	Therapeutic drug monitoring in inflammatory bowel disease treatments
Manuscript Source	Invited Manuscript
All Author List	Meng-Yao Wang, Jing-Wen Zhao, Chang-Qing Zheng and Li-Xuan Sang
ORCID	Author(s) ORCID Number Meng-Yao Wang http://orcid.org/0000-0002-6580-9324 Jing-Wen Zhao http://orcid.org/0000-0002-1587-2501 Chang-Qing Zheng http://orcid.org/0000-0003-4782-5715 Li-Xuan Sang http://orcid.org/0000-0002-4562-0022
Funding Agency and Grant Number
Corresponding Author	Li-Xuan Sang, MD, PhD, Associate Professor, Department of Gastroenterology, Shengjing Hospital of China Medical University, No. 39 Gliding Road, Tiexi District, Shenyang 110022, Liaoning Province, China. sanglixuan2008@163.com
Key Words	Therapeutic drug monitoring; Inflammatory bowel disease; Biologic therapies; Reactive; Proactive; Cost-effective
Core Tip	Therapeutic drug monitoring (TDM) has proven to be useful in the management of patients with inflammatory bowel disease (IBD). The therapeutic value, feasibility and application prospect of TDM in the treatment of IBD were discussed.
Publish Date	2022-04-15 08:25
Citation	Wang MY, Zhao JW, Zheng CQ, Sang LX. Therapeutic drug monitoring in inflammatory bowel disease treatments. World J Gastroenterol 2022; 28(15): 1604-1607
URL	https://www.wjgnet.com/1007-9327/full/v28/i15/1604.htm
DOI	https://dx.doi.org/10.3748/wjg.v28.i15.1604

Full Article (PDF)	WJG-28-1604.pdf
Full Article (Word)	WJG-28-1604.docx
Manuscript File	72579_Auto_Edited.docx
Answering Reviewers	72579-Answering reviewers.pdf
Audio Core Tip	72579-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	72579-Conflict-of-interest statement.pdf
Copyright License Agreement	72579-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	72579-Language certificate.pdf
Peer-review Report	72579-Peer-review(s).pdf
Scientific Misconduct Check	72579-Bing-Fan JR-2.png
Scientific Editor Work List	72579-Scientific editor work list.pdf